The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.


Ontario cancer research community gathers together for TFRI-Ontario Node Symposium

December 12, 2014 | Fabrice Sircoulomb and Maria José Sandi

In December we attended the TFRI Ontario Node Symposium at the MaRs collaboration centre in downtown Toronto. Part of our research work is supported by TFRI and as post-doctoral fellows researching ovarian and pancreatic cancer it was an amazing experience.

Read More View all blog posts

Watch our video about the Terry Fox Research Institute

News & Notices

  • Congratulations to TFRI researcher on $25 million funding for cancer biotherapeutics initiative

    The Terry Fox Research Institute congratulates Dr. John Bell and his team on their award of $25 million in funding from the Government of Canada's Networks of Centres of Excellence. Dr. Bell will launch Biotherapeutics for Cancer Treatment (BioCanRx), a new national initiative to move promising cancer biotherapeutics, such as cancer-killing viruses and immune cell therapies, from discovery to clinical trials.

    Read More View all notices

  • Call for Abstracts

    Are you a graduate student, postdoctoral trainee or clinical research fellow on a Terry Fox-funded project or program? The Terry Fox Research Institute invites you to compete for a travel award to attend our 6th Annual Scientific Meeting to be held in St. John’s, Newfoundland & Labrador on Thursday, May 7 to Saturday, May 9, 2015. For more information see

    Read More View all notices

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.